Silence Therapeutics
Silence Therapeutics is an England-based biotechnology company that develops RNA therapies for the treatment of cardiovascular, renal, metabolic and respiratory diseases.
Business Model:
Revenue: $16.9M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Silence Therapeutics Information
Geographic Data
Address: 72 Hammersmith Road
City: London
State: england
Zip: W14 8TH
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$20M
Raised Total:$129M
Social
Metrics
4,778,593Website Global Rank
1,803Website Monthly Traffic
Twitter Followers
Description
Silence Therapeutics is an England-based biotechnology company that develops RNA therapies for the treatment of cardiovascular, renal, metabolic and respiratory diseases.
Contact Phone:
Contact Email:
Silence Therapeutics went public on 12/18/2009 on the London Stock Exchange
Listed Exchange:
London Stock Exchange
IPO Date:
12/18/2009
Ticker Symbol:
SLN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2017 | Arrowhead Pharmaceuticals | Post-IPO Equity | 0 |
| 1/2017 | Arrowhead Pharmaceuticals | Post-IPO Equity | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Post-IPO Equity | $0 |
Adage Capital Management BVF Partners Consonance Capital Partners Great Point Partners Adage Capital Management BVF Partners Consonance Capital Partners Great Point Partners |
7/2019 | Post-IPO Equity | $0 |
Mallinckrodt Mallinckrodt Mallinckrodt Mallinckrodt |
11/2021 | Post-IPO Equity | 1 | $20M |
Frazier Healthcare Partners Frazier Healthcare Partners |
4/2015 | Post-IPO Equity | $58.2M | 8/2022 | Post-IPO Equity | $56.5M | 4/2015 | Unattributed | $58M | 5/2021 | Post-IPO Equity | $40M |
AstraZeneca |
4/2014 | Equity | $11.4M | 7/2019 | Equity | 1 | $5M |
Mallinckrodt plc Mallinckrodt Mallinckrodt |
2/2021 | Post-IPO Equity | 4 | $45.5M |
Adage Capital Management BVF Partners Consonance Capital Partners Great Point Partners Adage Capital Management BVF Partners Consonance Capital Partners Great Point Partners |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 12/2009 | Intradigm Corporation |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
